• Cryptocurrency that Cares

    I interviewed the top minds in the Bitcoin world about how nonprofits can benefits from this digital currency. Click here to learn more.

  • Writing and Publications

    Digital Strategy, Innovation, Co-Creation, Crowdfunding, Nonprofits, Volunteerism, Advocate Programs and Bitcoin are my passions. I often get to write about them. Click here to read more.

  • Speaking

    I've been keynoting and speaking at a variety of conferences for the last eight years. I'd love to hear more about yours. Click here to learn more.

Go out with a Boom or a thud?

American Demographics, a publication that measures the whimsies of populations segments and doles out marketing advice, put out an interesting June edition that focused mainly on the divisions that mark US society. One article, “The Second Coming of Age,” was about what’s ahead with the aging of the Baby Boom generation. Frankly, it’s not a particularly pretty sight. The sardonic ...

Read More »

Only way to increase long trem giving

Fundraisers in the UK have been told they will collectively have to switch their attention to targeting rich people and encouraging planned giving if they are to increase underlying giving levels over the next 25 years. This is based on the 25th Charity Trends Survey which also stated that things will get tougher over the next 25 years. Is this ...

Read More »

Tracking news

Heck, it’s not just those tykes in Japan that are getting tracking devices. http://www.wired.com/news/technology/0,1282,64194,00.html?tw=wn_tophead_6 State to Shadow Parolees With GPS New career for the future: Tracking Specialist. Reminds me of those old cowboy movies where the Indian guide would jump down off his horse, look at the hoofprints in the dirt and say, “Um, two men pass this way three ...

Read More »

Anti-cancer Agent Built From Anti-inflammatory Drug

This is interesting not just because it’s a promising new development in cancer treatment but because it was done using techniques that seem to be a modest advance in tools that might make drug design more cost effective.

Read More »